Analyst consensus rating

Caribou Biosciences Analyst Rating: Hold

Direct answer

Caribou Biosciences's consensus rating is Hold.

3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.00.
Forecast evidence checked November 22, 2026.

Get free Caribou Biosciences email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$0.28
Average price target
$5.00
High price target
$13.00
Low price target
$1.00
Low target gap
+251.7%
Target upside
+1,658.7%
High target gap
+4,472.6%
Target range width
4,220.9%
Consensus rating
Hold
Analysts
3
Evidence date
November 22, 2026
Valid through
November 29, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Caribou Biosciences?

Caribou Biosciences has a verified Hold consensus. The same dataset has an average price target of $5.00.

How far are Caribou Biosciences's low and high targets from the recorded price?

The low target implies +251.7%, while the high target implies +4,472.6%.

How many analysts are included in Caribou Biosciences's consensus?

The verified consensus includes 3 analysts.

How is Caribou Biosciences's target upside or downside calculated?

The average target of $5.00 is divided by the recorded price of $0.28, then one is subtracted to produce +1,658.7%. This does not guarantee a future return.

When was Caribou Biosciences's analyst forecast verified?

The data was verified on 2026-11-22. The dataset is valid through 2026-11-29.